Diagnosis of human immunodeficiency virus infection
BS Parekh, CY Ou, PN Fonjungo… - Clinical microbiology …, 2018 - Am Soc Microbiol
SUMMARY HIV diagnostics have played a central role in the remarkable progress in
identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral …
identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral …
[HTML][HTML] Technologies for HIV-1 drug resistance testing: inventory and needs
KJ Metzner - Current Opinion in HIV and AIDS, 2022 - journals.lww.com
The use of NGS technologies on HIV DR testing will allow unprecedented insights into
genomic structures of virus populations that may be of immediate relevance to both clinical …
genomic structures of virus populations that may be of immediate relevance to both clinical …
Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …
HIV-1 genotypic drug resistance testing: digging deep, reaching wide?
K Van Laethem, K Theys, AM Vandamme - Current opinion in virology, 2015 - Elsevier
Highlights•Technological innovations enable the global roll-out of drug resistance
surveillance.•Next-generation sequencing provides an answer for simultaneous resistance …
surveillance.•Next-generation sequencing provides an answer for simultaneous resistance …
Resistance of hepatitis C virus to inhibitors: complexity and clinical implications
Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-
species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent …
species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent …
RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients
EK Alidjinou, J Deldalle, C Hallaert… - Journal of …, 2017 - academic.oup.com
Background Sanger sequencing of plasma RNA is the standard method for HIV-1 drug
resistance testing in treatment-naive patients, but is limited by the non-detection of …
resistance testing in treatment-naive patients, but is limited by the non-detection of …
Utility of metagenomic next-generation sequencing for characterization of HIV and human pegivirus diversity
KC Luk, MG Berg, SN Naccache, B Kabre… - PloS one, 2015 - journals.plos.org
Given the dynamic changes in HIV-1 complexity and diversity, next-generation sequencing
(NGS) has the potential to revolutionize strategies for effective HIV global surveillance. In …
(NGS) has the potential to revolutionize strategies for effective HIV global surveillance. In …
HIV therapy—the state of art
D Looney, A Ma, S Johns - The Future of HIV-1 Therapeutics: Resistance …, 2015 - Springer
HIV Attachment. In this cross section, HIV is shown at the top and a target cell is shown at the
bottom in blues. HIV envelope protein (A) has bound to the receptor CD4 (B) and then to …
bottom in blues. HIV envelope protein (A) has bound to the receptor CD4 (B) and then to …
Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism …
N Silver, M Paynter, G McAllister, M Atchley… - AIDS research and …, 2018 - Springer
Background The widespread global access to antiretroviral drugs has led to considerable
reductions in morbidity and mortality but, unfortunately, the risk of virologic failure increases …
reductions in morbidity and mortality but, unfortunately, the risk of virologic failure increases …
Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
Background Viral resistance to antiretroviral therapy threatens our best methods to control
and prevent HIV infection. Current drug resistance genotyping methods are costly, optimized …
and prevent HIV infection. Current drug resistance genotyping methods are costly, optimized …